Market closed

Nevro/$NVRO

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Nevro

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Ticker

$NVRO

Sector

Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Redwood City, United States

Employees

1,215

Website

nevro.com

Nevro Metrics

BasicAdvanced

$151M

-

-$1.89

0.93 -

Price and volume

Market cap

$151M

Beta

0.93

52-week high

$19.47

52-week low

$3.17

Average daily volume

465K

Financial strength

Current ratio

5.023

Quick ratio

3.644

Long term debt to equity

76.262

Total debt to equity

90.239

Interest coverage (TTM)

-3.56%

Management effectiveness

Return on assets (TTM)

-9.02%

Return on equity (TTM)

-24.78%

Valuation

Price to revenue (TTM)

0.353

Price to book

0.55

Price to tangible book (TTM)

0.72

Price to free cash flow (TTM)

-2.616

Growth

Revenue change (TTM)

-0.87%

Earnings per share change (TTM)

-34.34%

3-year revenue growth (CAGR)

2.09%

3-year earnings per share growth (CAGR)

-15.46%

What the Analysts think about Nevro

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Nevro stock.

Nevro Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Nevro Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Nevro News

AllArticlesVideos

Nevro Corp. (NVRO) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NVRO

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Nevro stock?

Nevro (NVRO) has a market cap of $151M as of January 15, 2025.

What is the P/E ratio for Nevro stock?

The price to earnings (P/E) ratio for Nevro (NVRO) stock is 0 as of January 15, 2025.

Does Nevro stock pay dividends?

No, Nevro (NVRO) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Nevro dividend payment date?

Nevro (NVRO) stock does not pay dividends to its shareholders.

What is the beta indicator for Nevro?

Nevro (NVRO) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.